• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Nakajo-Nishimura 综合征伴肌浆内包涵体的肌炎:一种遗传性炎症性肌病。

Myositis with sarcoplasmic inclusions in Nakajo-Nishimura syndrome: a genetic inflammatory myopathy.

机构信息

Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Center for Educational Research and Development, Wakayama Medical University, Wakayama, Japan.

出版信息

Neuropathol Appl Neurobiol. 2020 Oct;46(6):579-587. doi: 10.1111/nan.12614. Epub 2020 Mar 25.

DOI:10.1111/nan.12614
PMID:32144790
Abstract

AIMS

Nakajo-Nishimura syndrome (NNS) is an autosomal recessive disease caused by biallelic mutations in the PSMB8 gene that encodes the immunoproteasome subunit β5i. There have been only a limited number of reports on the clinicopathological features of the disease in genetically confirmed cases.

METHODS

We studied clinical and pathological features of three NNS patients who all carry the homozygous p.G201V mutations in PSMB8. Patients' muscle specimens were analysed with histology and immunohistochemistry.

RESULTS

All patients had episodes of typical periodic fever and skin rash, and later developed progressive muscle weakness and atrophy, similar to previous reports. Oral corticosteroid was used for treatment but showed no obvious efficacy. On muscle pathology, lymphocytes were present in the endomysium surrounding non-necrotic fibres, as well as in the perimysium perivascular area. Nearly all fibres strongly expressed MHC-I in the sarcolemma. In the eldest patient, there were abnormal protein aggregates in the sarcoplasm, immunoreactive to p62, TDP-43 and ubiquitin antibodies.

CONCLUSIONS

These results suggest that inflammation, inclusion pathology and aggregation of abnormal proteins underlie the progressive clinical course of the NNS pathomechanism.

摘要

目的

Nakajo-Nishimura 综合征(NNS)是一种常染色体隐性疾病,由 PSMB8 基因的双等位基因突变引起,该基因编码免疫蛋白酶体亚基β5i。在基因确诊病例中,该疾病的临床病理特征仅有少数报道。

方法

我们研究了 3 名 NNS 患者的临床和病理特征,他们均携带 PSMB8 中的纯合 p.G201V 突变。对患者的肌肉标本进行组织学和免疫组织化学分析。

结果

所有患者均有典型的周期性发热和皮疹发作,随后出现进行性肌肉无力和萎缩,与以往报道相似。曾使用口服皮质类固醇治疗,但无明显疗效。肌肉病理学检查显示,在非坏死纤维周围的肌内膜和血管周围的肌周膜中存在淋巴细胞。几乎所有纤维的肌膜上均强烈表达 MHC-I。在最年长的患者中,肌浆中存在 p62、TDP-43 和泛素抗体免疫反应性的异常蛋白聚集体。

结论

这些结果表明,炎症、包涵体病理学和异常蛋白的聚集是 NNS 发病机制进行性临床病程的基础。

相似文献

1
Myositis with sarcoplasmic inclusions in Nakajo-Nishimura syndrome: a genetic inflammatory myopathy.Nakajo-Nishimura 综合征伴肌浆内包涵体的肌炎:一种遗传性炎症性肌病。
Neuropathol Appl Neurobiol. 2020 Oct;46(6):579-587. doi: 10.1111/nan.12614. Epub 2020 Mar 25.
2
A Chinese case of Nakajo-Nishimura syndrome with novel compound heterozygous mutations of the PSMB8 gene.一例 Nakajo-Nishimura 综合征的中国病例,其 PSMB8 基因存在新型复合杂合突变。
BMC Med Genet. 2020 Jun 8;21(1):126. doi: 10.1186/s12881-020-01060-8.
3
Nakajo-Nishimura syndrome: an autoinflammatory disorder showing pernio-like rashes and progressive partial lipodystrophy.中城西村综合征:一种表现为冻疮样皮疹和进行性部分脂肪营养不良的自身炎症性疾病。
Allergol Int. 2012 Jun;61(2):197-206. doi: 10.2332/allergolint.11-RAI-0416. Epub 2012 Mar 25.
4
[Nakajo-Nishimura syndrome].中条-西村综合征
Nihon Rinsho Meneki Gakkai Kaishi. 2011;34(5):388-400. doi: 10.2177/jsci.34.388.
5
A new infant case of Nakajo-Nishimura syndrome with a genetic mutation in the immunoproteasome subunit: an overlapping entity with JMP and CANDLE syndrome related to PSMB8 mutations.免疫蛋白酶体亚基基因突变导致的 Nakajo-Nishimura 综合征新婴儿病例:与 JMP 和 CANDLE 综合征相关的 PSMB8 突变重叠实体。
Dermatology. 2013;227(1):26-30. doi: 10.1159/000351323. Epub 2013 Aug 8.
6
Chinese case of Nakajo-Nishimura syndrome with a novel mutation of the PSMB8 gene.携带PSMB8基因新突变的纳卡乔-西村综合征中国病例。
J Dermatol. 2019 May;46(5):e160-e161. doi: 10.1111/1346-8138.14679. Epub 2018 Nov 2.
7
Pluripotent Stem Cell Model of Nakajo-Nishimura Syndrome Untangles Proinflammatory Pathways Mediated by Oxidative Stress.氧化应激介导的炎症通路的解析:Nakajo-Nishimura 综合征的多能干细胞模型。
Stem Cell Reports. 2018 Jun 5;10(6):1835-1850. doi: 10.1016/j.stemcr.2018.04.004. Epub 2018 May 3.
8
Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome.蛋白酶体组装缺陷由于蛋白酶体亚基β类型 8(PSMB8)突变导致自炎症性疾病,中鹤-西村综合征。
Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14914-9. doi: 10.1073/pnas.1106015108. Epub 2011 Aug 18.
9
Nakajo-Nishimura syndrome and related proteasome-associated autoinflammatory syndromes.中条-西村综合征及相关蛋白酶体相关自身炎症性综合征。
J Inflamm Res. 2019 Sep 17;12:259-265. doi: 10.2147/JIR.S194098. eCollection 2019.
10
Nakajo-Nishimura Syndrome: The First African Case.中条-西村综合征:首例非洲病例。
Mediterr J Rheumatol. 2023 Jun 30;34(2):262-265. doi: 10.31138/mjr.34.2.262. eCollection 2023 Jun.

引用本文的文献

1
Genetics of myositis - distinct backgrounds of subtypes.肌炎的遗传学——各亚型的不同背景。
J Hum Genet. 2025 Jul 30. doi: 10.1038/s10038-025-01374-6.
2
Inclusion body myositis, viral infections, and TDP-43: a narrative review.包涵体肌炎、病毒感染与 TDP-43:一篇叙述性综述
Clin Exp Med. 2024 May 2;24(1):91. doi: 10.1007/s10238-024-01353-9.
3
LATE-NC staging in routine neuropathologic diagnosis: an update.常规神经病理诊断中的晚期神经节细胞(stage)分期:更新。
Acta Neuropathol. 2023 Feb;145(2):159-173. doi: 10.1007/s00401-022-02524-2. Epub 2022 Dec 13.
4
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS.2021 年欧洲风湿病学会联盟/美国风湿病学会关于自身炎症性 I 型干扰素病的诊断和治疗的考虑要点:CANDLE/PRAAS、SAVI 和 AGS。
Ann Rheum Dis. 2022 May;81(5):601-613. doi: 10.1136/annrheumdis-2021-221814. Epub 2022 Jan 27.
5
The role of interferons type I, II and III in myositis: A review.Ⅰ型、Ⅱ型和Ⅲ型干扰素在肌炎中的作用:综述。
Brain Pathol. 2021 May;31(3):e12955. doi: 10.1111/bpa.12955.
6
Pluripotent stem cell-based screening identifies CUDC-907 as an effective compound for restoring the in vitro phenotype of Nakajo-Nishimura syndrome.基于多能干细胞的筛选发现 CUDC-907 是一种有效化合物,可恢复 Nakajo-Nishimura 综合征的体外表型。
Stem Cells Transl Med. 2021 Mar;10(3):455-464. doi: 10.1002/sctm.20-0198. Epub 2020 Oct 14.